Psychological Distance,Construal Level,and Parental Vaccine Hesitancy for COVID-19,HPV,and Monkey Pox Vaccines

Abstract

Building on the construal-level theory and the multi-dimensional model of behavioral barriers, this study examined whether psychological distance and construal level explain the association between behavioral intention and behavioral barriers that may lead to parental vaccine hesitancy. Results of multilevel structural equation models show that low vaccination intention, far distance perception, and abstract construal of vaccines led to more global concerns, such as vaccine safety and relevance. Such effects emerged when people considered specific vaccines, such as coronavirus disease 2019 (COVID-19), human papillomavirus (HPV), and monkeypox vaccines, and when they considered multiple vaccines in general.

Keywords

psychological distance construal vaccine hesitancy behavioral barrier

Get full access to this article

View all access options for this article.

References

American Academy of Pediatrics. (2022). Children and COVID-19 vaccination trends. https://www.aap.org/en/pages/2019-novel-coronavirus-covid-19-infections/children-and-covid-19-vaccination-trends/#:~:text=Children%20Ages%206%20Months%2D4%20Years%3A%209%25%20had%20received,dose%20of%20COVID%2D19%20vaccine

Bosker

Snijders

T. A.

(2011). Multilevel analysis: An introduction to basic and advanced multilevel modeling. Sage.

Centers for Disease Control and Prevention. (1999). Ten great public health achievements—United States, 1900-1999 (0149-2195) [MMWR. Morbidity and Mortality Weekly Report, Issue]. https://www.cdc.gov/mmwr/preview/mmwrhtml/00056796.htm

Centers for Disease Control and Prevention. (2021). Vaccine (shot) for human papillomavirus. https://www.cdc.gov/vaccines/parents/diseases/hpv.html

Centers for Disease Control and Prevention. (2022). 2022 outbreak cases and data. https://www.cdc.gov/poxvirus/monkeypox/response/2022/index.html

Chido-Amajuoyi

O. G.

Jackson

Shete

(2021). Declining awareness of HPV and HPV vaccine within the general U.S. population. Human Vaccines & Immunotherapeutics, 17(2), 420–427.

Chu

(2022). Construing climate change: Psychological distance, individual difference, and construal level of climate change. Environmental Communication, 16, 883–899.

Chu

Liu

(2021a). Integrating health behavior theories to predict American’s intention to receive a COVID-19 vaccine. Patient Education and Counseling, 104(8), 1878–1886.

Chu

Liu

(2021b). Light at the end of the tunnel: Influence of vaccine availability and vaccination intention on people’s consideration of the COVID-19 vaccine. Social Science & Medicine, 286, 114315.

10.

Dubé

È.

Laberge

Guay

Bramadat

Roy

Bettinger

J. A.

(2013). Vaccine hesitancy: An overview. Human Vaccines & Immunotherapeutics, 9(8), 1763–1773.

11.

Förster

Liberman

Higgins

E. T.

(2005). Accessibility from active and fulfilled goals. Journal of Experimental Social Psychology, 41(3), 220–239.

12.

Fujita

(2008). Seeing the forest beyond the trees: A construal-level approach to self-control. Social and Personality Psychology Compass, 2(3), 1475–1496.

13.

Gerend

M. A.

Shepherd

M. A.

Shepherd

J. E.

(2013). The multi-dimensional nature of perceived barriers: Global versus practical barriers to HPV vaccination. Health Psychology, 32(4), 361–369.

14.

Huang

F. L.

Cornell

D. G.

(2016). Using multilevel factor analysis with clustered data: Investigating the factor structure of the Positive Values Scale. Journal of Psychoeducational Assessment, 34(1), 3–14.

15.

Kelly

B. J.

Southwell

B. G.

McCormack

L. A.

Bann

C. M.

MacDonald

P. D.

Frasier

A. M.

. . . Squiers

L. B.

(2021). Predictors of willingness to get a COVID-19 vaccine in the U.S. BMC Infectious Diseases, 21(1), Article 338.

16.

Kline

R. B.

(2015). Principles and practice of structural equation modeling. Guilford Press.

17.

Larson

H. J.

Jarrett

Eckersberger

Smith

D. M.

Paterson

(2014). Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: A systematic review of published literature, 2007–2012. Vaccine, 32(19), 2150–2159.

18.

Liberman

Trope

(1998). The role of feasibility and desirability considerations in near and distant future decisions: A test of temporal construal theory. Journal of Personality and Social Psychology, 75(1), 5–18.

19.

Liu

Yang

J. Z.

Chu

Sun

(2018). Different culture or different mind? Perception and acceptance of HPV vaccine in China and in the U.S. Journal of Health Communication, 23(12), 1008–1016.

20.

N. C.

Hotez

P. J.

(2017). Public health and economic consequences of vaccine hesitancy for measles in the United States. JAMA Pediatrics, 171(9), 887–892.

21.

Loomba

de Figueiredo

Piatek

S. J.

de Graaf

Larson

H. J.

(2021). Measuring the impact of COVID-19 vaccine misinformation on vaccination intent in the UK and USA. Nature Human Behaviour, 5(3), 337–348.

22.

Margolis

M. A.

Brewer

N. T.

Boynton

M. H.

Lafata

J. E.

Southwell

B. G.

Gilkey

M. B.

(2022). Provider response and follow-up to parental declination of HPV vaccination. Vaccine, 40(2), 344–350.

23.

Minhaj

F. S.

Ogale

Y. P.

Whitehill

Schultz

Foote

Davidson

Hughes

C. M.

Wilkins

Bachmann

Chatelain

(2022). Monkeypox outbreak—Nine states, May 2022. Morbidity and Mortality Weekly Report, 71(23), 764.

24.

Muthén

(2010). Bayesian analysis in Mplus: A brief introduction. https://www.statmodel.com/download/IntroBayesVersion%203.pdf

25.

Muthén

(2017). Mplus. In van der Linden

W. J.

(Ed.), Handbook of item response theory (pp. 507–518). Chapman and Hall/CRC.

26.

Muthén

L. K.

Muthén

(2008). Mplus short courses topic 1 exploratory factor analysis, confirmatory factor analysis, and structural equation modeling for continuous outcomes. https://www.statmodel.com/download/Topic%201.pdf

27.

Nguyen

K. H.

Santibanez

T. A.

Stokley

Lindley

M. C.

Fisher

Kim

. . . Singleton

(2021). Parental vaccine hesitancy and its association with adolescent HPV vaccination. Vaccine, 39(17), 2416–2423.

28.

Palan

Schitter

(2018). Prolific. ac—A subject pool for online experiments. Journal of Behavioral and Experimental Finance, 17, 22–27.

29.

Preacher

K. J.

Zhang

Kim

Mels

(2013). Choosing the optimal number of factors in exploratory factor analysis: A model selection perspective. Multivariate Behavioral Research, 48(1), 28–56.

30.

Ruiz

J. B.

Bell

R. A.

(2022). Parental COVID-19 vaccine hesitancy in the United States. Public Health Reports, 137(6), 1162–1169.

31.

Santibanez

T. A.

Nguyen

K. H.

Greby

S. M.

Fisher

Scanlon

Bhatt

Srivastav

Singleton

J. A.

(2020). Parental vaccine hesitancy and childhood influenza vaccination. Pediatrics, 146(6), e2020007609.

32.

Schweig

(2014). Cross-level measurement invariance in school and classroom environment surveys: Implications for policy and practice. Educational Evaluation and Policy Analysis, 36(3), 259–280.

33.

Southwell

B. G.

(2005). Between messages and people: A multilevel model of memory for television content. Communication Research, 32(1), 112–140.

34.

Stevens

(2009). Applied multivariate statistics for the social sciences (5th ed.). Lawrence Erlbaum.

35.

Szilagyi

P. G.

Albertin

C. S.

Gurfinkel

Saville

A. W.

Vangala

Rice

J. D.

. . . Kempe

(2020). Prevalence and characteristics of HPV vaccine hesitancy among parents of adolescents across the U.S. Vaccine, 38(38), 6027–6037.

36.

Trope

Liberman

(2010). Construal-level theory of psychological distance. Psychological Review, 117(2), 440–463.

37.

U.S. Food and Drug Administration. (2022). Monkeypox update: FDA authorizes emergency use of JYNNEOS vaccine to increase vaccine supply. https://www.fda.gov/news-events/press-announcements/monkeypox-update-fda-authorizes-emergency-use-jynneos-vaccine-increase-vaccine-supply

38.

Vouga

Nielsen-Saines

Dashraath

Baud

(2022). The monkeypox outbreak: Risks to children and pregnant women. The Lancet Child & Adolescent Health, 6(11), 751–753.

39.

Wagner

A. L.

Boulton

M. L.

Sun

Mukherjee

Huang

Harmsen

I. A.

Ren

Zikmund-Fisher

B. J.

(2017). Perceptions of measles, pneumonia, and meningitis vaccines among caregivers in Shanghai, China, and the health belief model: A cross-sectional study. BMC Pediatrics, 17(1), Article 143.

40.

Walter

E. B.

Talaat

K. R.

Sabharwal

Gurtman

Lockhart

Paulsen

G. C.

Barnett

E. D.

Muñoz

F. M.

Maldonado

Pahud

B. A.

(2022). Evaluation of the BNT162b2 Covid-19 vaccine in children 5 to 11 years of age. The New England Journal of Medicine, 386(1), 35–46.

41.

Weinstein

N. D.

(1993). Testing four competing theories of health-protective behavior. Health Psychology, 12(4), 324–333.

42.

World Health Organization. (2011). The immunological basis for immunization series: Module 19: human papillomavirus infection. https://apps.who.int/iris/handle/10665/44604

43.

World Health Organization. (2022). WHO Coronavirus (COVID-19) dashboard. https://covid19.who.int/